Antigen-induced generation of lyso-phospholipids in human airways

Journal of Experimental Medicine

Volumn 183, Issue 5, 1996, Pages 2235-2245

  Chilton, Floyd H ^a   Averill, Francis J ^b   Hubbard, Walter C ^b   Fonteh, Alfred N ^a   Triggiani, Massimo ^c   Liu, Mark C ^b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOLIPID; PROSTAGLANDIN D2;

ADULT; AIRWAY OBSTRUCTION; ANTIGEN ANTIBODY REACTION; ARTICLE; BRONCHOSCOPY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GAS CHROMATOGRAPHY; HUMAN; IMMUNE RESPONSE; LIPID METABOLISM; LUNG LAVAGE; MASS SPECTROMETRY; POPULATION RESEARCH; PRIORITY JOURNAL;

ADULT; ASTHMA; BRONCHOALVEOLAR LAVAGE; BRONCHOALVEOLAR LAVAGE FLUID; DINOPROST; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; HYPERSENSITIVITY; LYSOPHOSPHOLIPIDS; MALE; METHACHOLINE CHLORIDE; PROSTAGLANDIN D2; REFERENCE VALUES; RHINITIS; TIME FACTORS;

EID: 0029975402     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.183.5.2235     Document Type: Article

References (66)

1. Djukanovic, R., W.R. Roche, J.W. Wilson, C.R. Beasley, O.P. Twentyman, R.H. Howarth, and S.T. Holgate. 1990. Mucosal inflammation in asthma. Am. Rev. Respir. Dis. 142: 434-457.
2. Triggiani, M., R.P. Schleimer, J.A. Warner, and F.H. Chilton. 1991. Differential synthesis of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine and platelet-activating factor by human inflammatory cells. J. Immunol. 147:660-666.
3. Mencia-Huerta, J.M., R.A. Lewis, E. Razin, and K.F. Austen. 1983. Antigen-initiated release of platelet-activating factor (PAF-acether) from mouse bone marrow-derived mast cells sensitized with monoclonal IgE. J. Immunol. 131:2958-2964.
4. Wasserman, S.I. 1988. Platelet-activating factor as a mediator of bronchial asthma [published erratum appears in Hosp Pract (Off Ed) 1989 Jan 15; 24(1):17]. Hosp. Pract. (Off. Ed.). 23: 49-58.
5. Rubin, A.H., L.J. Smith, and R. Patterson. 1987. The bronchoconstrictor properties of platelet-activating factor in humans. Am. Rev. Respir. Dis. 136:1145-1151.
6. Stimler, N.P., and J.T. O'Flaherty. 1983. Spasmogenic properties of platelet-activating factor: evidence for a direct mechanism in the contractile response of pulmonary tissues. Am. J. Pathol. 113:75-84.
7. Smith, L.J. 1991. The role of platelet-activating factor in asthma. Am. Rev. Respir. Dis. 143:S100-102.
8. Henson, P.M., P.J. Barnes, and S.P. Banks-Schlegel. 1992. NHLBI workshop summary. Platelet-activating factor: role in pulmonary injury and dysfunction and blood abnormalities. Am. Rev. Respir. Dis. 145:726-731.
9. Denjean, A., B. Arnoux, R. Masse, A. Lockhart, and J. Benveniste. 1983. Acute effects of intratracheal administration of platelet-activating factor in baboons. J. Appl. Phys. Respir. Environ. Exercise Physiol. 55:799-804.
10. Patterson, R., P.R. Bernstein, K.E. Harris, and R.D. Krell. 1984. Airway responses to sequential challenges with platelet-activating factor and leukotriene D4 in rhesus monkeys. J. Lab. Clin. Med. 104:340-345.
11. Nakamura, T., Y. Morita, M. Kuriyama, K. Ishihara, K. Ito, and T. Miyamoto. 1987. Platelet-activating factor in late asthmatic response. Int. Arch. Allergy Appl. Immunol. 82:57-61.
12. Stenton, S.C., E.N. Court, W.P. Kingston, P. Goadby, C.A. Kelly, M. Duddridge, C. Ward, D.J. Hendrick, and E.H. Walters. 1990. Platelet-activating factor in bronchoalveolar lavage fluid from asthmatic subjects. Eur. Respir. J. 3:408-413.
13. Cuss, F.M., C.M. Dixon, and P.J. Barnes. 1986. Effects of inhaled platelet activating factor on pulmonary function and bronchial responsiveness in man. Lancet. 2:189-192.
14. Chung, K.F., H. Aizawa, G.D. Leikauf, I.F. Ueki, T.W. Evans, and J.A. Nadel. 1986. Airway hyperresponsiveness induced by platelet-activating factor: role of thromboxane generation. J. Pharmacol. Exp. Ther. 236:580-584.
15. Smith, L.J., A.H. Rubin, and R. Patterson. 1988. Mechanism of platelet activating factor-induced bronchoconstriction in humans. Am. Rev. Respir. Dis. 137:1015-1019.
16. Vargaftig, B.B., J. Lefort, M. Chignard, and J. Benveniste. 1980. Platelet-activating factor induces a platelet-dependent bronchoconstriction unrelated to the formation of prostaglandin derivatives. Eur. J. Pharmacol. 65:185-192.
17. Akita, H., M.H. Creer, K.A. Yamada, B.E. Sobel, and P.B. Corr. 1986. Electrophysiologic effects of intracellular lysophosphoglycerides and their accumulation in cardiac lymph with myocardial ischemia in dogs. J. Clin. Invest. 78:271-280.
18. Snyder, D.W., W.A. Crafford, Jr., J.L. Glashow, D. Rankin, B.E. Sobel, and P.B. Corr. 1981. Lysophosphoglycerides in ischemic myocardium effluents and potentiation of their arrhythmogenic effects. Am. J. Physiol. 241:H700-H707.
19. Govier, W.C., and M.C. Boadle. 1967. The cardiac action of lysolecithin. J. Pharmacol. Exp. Ther. 156:339-344.
20. Sedlis, S.P., M. Hom, J.M. Sequeira, and R Esposito. 1993. Lysophosphatidylcholine accumulation in ischemic human myocardium. J. Lab. Clin. Med. 121:111-117.
21. Man, R.Y. 1988. Lysophosphatidylcholine-induced arrhythmias and its accumulation in the rat perfused heart. Br. J. Pharmacol. 93:412-416.
22. Clarkson, C.W., and R.E. Ten Eick. 1983. On the mechanism of lysophosphatidylcholine-induced depolarization of cat ventricular myocardium. Circ. Res. 52:543-556.
23. Sedlis, S.P., J.M. Sequeira, G.G. Ahumada, and N. el Sherif. 1988. Effects of lysophosphatidylcholine on cultured heart cells: correlation of rate of uptake and extent of accumulation with cell injury. J. Lab. Clin. Med. 112:745-754.
24. Weltzien, H.U. 1979. Cytolytic and membrane-perturbing properties of lysophosphatidylcholine. Biochim. Biophys. Acta. 559:259-287.
25. Sargent, C.A., O. Vesterqvist, M.L. Ogletree, and G.J. Grover. 1993. Effects of endogenous and exogenous lysophosphatidylcholine in isolated perfused rat hearts. J. Mol. Cell. Cardiol. 25:905-913.
26. Boachie-Ansah, G., K.A. Kane, and A.C. Rankin. 1992. Effects of a combination of acidosis, lactate, and lysophosphatidylcholine on action potentials and ionic currents in guinea pig ventricular myocytes. J. Cardiovasc. Pharmacol. 20:538-546.
27. Woodley, S.L., H. Ikenouchi, and W. H. Barry. 1991. Lysophosphatidylcholine increases cytosolic calcium in ventricular myocytes by direct action on the sarcolemma. J. Mol. Cell. Cardiol. 23:671-680.
28. Liu, E., J.I. Goldhaber, and J.N. Weiss. 1991. Effects of lysophosphatidylcholine on electrophysiological properties and excitation-contraction coupling in isolated guinea pig ventricular myocytes. J. Clin. Invest. 88:1819-1832.
29. Niewoehner, D.E., K. Rice, A.A. Sinha, and D. Wangensteen. 1987. Injurious effects of lysophosphatidylcholine on barrier properties of alveolar epithelium. J. Appl. Physiol. 63: 1979-1986.
30. Amirkhanian, J.D., and H.W. Taeusch. 1993. Reversible and irreversible inactivation of preformed pulmonary surfactant surface films by changes in subphase constituents. Biochim. Biophys. Acta. 1165:321-326.
31. Lindahl, M., A.R. Hede, and C. Tagesson. 1986. Lysophosphatidylcholine increases airway and capillary permeability in the isolated perfused rat lung. Exp. Lung Res. 11:1-12.
32. Rice, K.L., P.G. Duane, and D.E. Niewoehner. 1988. Effects of phospholipase A2 and its hydrolytic products on alveolar epithelial permeability and elastase-induced emphysema. Am. Rev. Respir. Dis. 138:1196-1200.
33. 2. J. Appl. Physiol. 66:261-267.
34. 2. J. Biol. Chem. 269:13057-13060.
35. 2. J. Biol. Chem. 269:2365-2368.
36. 2 present in rheumatoid arthritic synovial fluid. J. Biol. Chem. 264:5335-5338.
37. 2. J. Biol. Chem. 264:5768-5775.
38. 2 and its characteristics. J. Biochem. 105:520-525.
39. 2 from activated mast cells and its possible involvement in the regulation of the degranulation process. Eur. J. Biochem. 209:257-265.
40. 2 plays a role in arachidonic acid release and eicosanoid biosynthesis by mast cells. J. Immunol. 152:5438-5446.
41. 2 purified from an inflammatory exudate. Biochemistry. 25:8381-8385.
42. 2 activity in sera and synovial fluids in rheumatoid arthritis and osteoarthritis. Its possible role as a proinflammatory enzyme. J. Rheumatol. 12:211-216.
43. 2 from human nasal lavage. Am. J. Respir. Cell Mol. Biol. 11: 108-113.
44. 2 into nasal fluids after allergenic challenge: possible role in the regulation of platelet activating factor release. J. Allergy Clin. Immunol. 94:109-119.
45. 2 in inflammatory diseases. Clin. Chem. 39:2453-2459.
46. 2 regulates critical inflammatory mediators of multiple organ failure. J. Surg. Res. 56:199-205.
47. Farr, R.S., M.L. Wardlow, C.P. Cox, K.E. Meng, and D.E. Greene. 1983. Human serum acid-labile factor is an acylhydrolase that inactivates platelet-activating factor. Fed. Proc. 42: 3120-3122.
48. Elstad, M.R., D.M. Stafforini, S.M. Prescott, and T.M. McIntyre. 1991. Human macrophages secrete platelet-activating factor acetylhydrolase. A mechanism for resolution of pulmonary inflammation. Chest. 99:9S-10S.
49. Stafforini, D.M., E.N. Rollins, S.M. Prescott, and T.M. McIntyre. 1993. The platelet-activating factor acetylhydrolase from human erythrocytes. Purification and properties. J. Biol. Chem. 268:3857-3865.
50. Tjoelker, L.W., C. Wilder, C. Eberhardt, D.M. Stafforni, G. Dietsch, B. Schimpf, S. Hooper, H. LeTrong, L.S. Cousens, and G.A. Zimmerman. 1995. Anti-inflammatory properties of a platelet-activating factor acetylhydrolase. Nature (Lond.). 374:549-553.
51. Lui, M.C., W.C. Hubbard, D. Proud, B.A. Stealey, S.J. Galli, A. Kagey-Sobotka, E.R. Bleecker, and L.M. Lichtenstein. 1991. Immediate and late inflammatory responses to ragweed antigen challenge of the peripheral airways in allergic asthmatics. Cellular, mediator, and permeability changes. Am. Rev. Respir. Dis. 144:51-58.
52. Anonymous. 1985. Summary and recommendations of a workshop on the investigative use of fiberoptic bronchoscopy and bronchoalveolar lavage in asthmatics. Am. Rev. Respir. Dis. 132:180-185.
53. Ramesha, C.S., and W.C. Pickett. 1986. Measurement of sub-picogram quantities of platelet activating factor (AGEPC) by gas chromatography/negative ion chemical ionization mass spectrometry. Biomed. Environ. Mass Spertrom. 13:107-111.
54. Murphy, R.C., and K.L. Clay. 1987. Measurement of platelet-activating factor by physicochemical techniques. Am. Rev. Respir. Dis. 136:207-210.
55. Janero, D.R., and C. Burghardt. 1990. Solid-phase extraction on silica cartridges as an aid to platelet-activating factor enrichment and analysis. J. Chromatogr. 526:11-24.
56. 2, and other bronchoconstricting prostaglandins in the airways of subjects with mild asthma. Am. Rev. Respir. Dis. 142:126-132.
57. Shin, M.-H., F.J. Averill, W.C. Hubbard, F.H. Chilton, F.M. Baroody, M.C. Liu, and R.M. Naclerio. 1994. 1-0-hexadecyl-2-lyso-sn-glycero-3-phospholipid generation after nasal challenge with allergen. Am. J. Respir. Crit. Care Med. 149:660-666.
58. Rennard, S.I, G. Basset, D. Lecossier, K.M. O'Donnell, P. Pinkston, P.G. Martin, and R.G. Crystal. 1986. Estimation of volume of epithelial lining fluid recovered by lavage using urea as a marker of dilution. J. Appl. Physiol. 60:532-538.
59. Chilton, F.H., J.M. Ellis, S.C. Olson, and R.L. Wykle. 1984. 1-0-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine. A common source of platelet-activating factor and arachidonate in human polymorphonuclear leukocytes. J. Biol. Chem. 259: 12014-12019.
60. Nakano, T., E.W. Raines, J.A. Abraham, M. Klagsbrun, and R. Ross. 1994. Lysophosphatidylcholine upregulates the level of heparin-binding epidermal growth factor-like growth factor mRNA in human monocytes. Proc. Natl. Acad. Sci. USA. 91:1069-1073.
61. Kume, N., and M.A. Gimbrone, Jr. 1994. Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells. J. Clin. Invest. 93: 907-911.
62. Zimmerman, G.A., S.M. Prescott, and T.M. McIntyre. 1995. Oxidatively fragmented phospholipids as inflammatory mediators: the dark side of polyunsaturated lipids. [Review]. J. Nutrition. 125(6 Supp.):1661S-1665S.
63. Watson, A.D., M. Navab, S.Y. Hama, A. Sevanian, S.M. Prescott, D.M. Stafforini, T.M. McIntyre, B.N. Du, A.M. Fogelman, and J.A. Berliner. 1995. Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein. J. Clin. Invest. 95:774-782.
64. 2 receptor. J. Biol. Chem. 269:5897-5904.
65. 2. J. Biol. Chem. 269:1575-1578.
66. Triggiani, M., W.C. Hubbard, and F.H. Chilton. 1990. Synthesis of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine by an enriched preparation of the human lung mast cell. J. Immunol. 144:4773-4780.